Your browser doesn't support javascript.
loading
Sequential administration of nivolumab and ipilimumab with a planned switch in patients with advanced melanoma (CheckMate 064): an open-label, randomised, phase 2 trial.
Weber, Jeffrey S; Gibney, Geoff; Sullivan, Ryan J; Sosman, Jeffrey A; Slingluff, Craig L; Lawrence, Donald P; Logan, Theodore F; Schuchter, Lynn M; Nair, Suresh; Fecher, Leslie; Buchbinder, Elizabeth I; Berghorn, Elmer; Ruisi, Mary; Kong, George; Jiang, Joel; Horak, Christine; Hodi, F Stephen.
Afiliação
  • Weber JS; New York University Langone Medical Center, New York, NY, USA; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Gibney G; H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Sullivan RJ; Massachusetts General Hospital, Boston, MA, USA.
  • Sosman JA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Slingluff CL; University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Lawrence DP; Massachusetts General Hospital, Boston, MA, USA.
  • Logan TF; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Schuchter LM; University of Pennsylvania, Philadelphia, PA, USA.
  • Nair S; Lehigh Valley Health Network, Allentown, PA, USA.
  • Fecher L; Indiana University Simon Cancer Center, Indianapolis, IN, USA; University of Michigan, Ann Arbor, MI, USA.
  • Buchbinder EI; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Berghorn E; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Ruisi M; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Kong G; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Jiang J; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Horak C; Bristol-Myers Squibb, Princeton, NJ, USA.
  • Hodi FS; Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: stephen_hodi@dfci.harvard.edu.
Lancet Oncol ; 17(7): 943-955, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27269740
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Protocolos de Quimioterapia Combinada Antineoplásica / Melanoma Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos